Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06096688 · ClinicalTrials.gov registry record
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
A clinical trial of Colorectal Cancer and Endometrial Cancer, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- 1,120
- Enrollment target
- 1
- Study location
NCT06096688 is a study of Colorectal Cancer and Endometrial Cancer that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 1,120 participants, below the 1,508-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06096688, a study of Colorectal Cancer and Endometrial Cancer, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- 1,120 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studies.
Conditions Studied
Study Locations (1)
New York
- NYP/Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,120 participants |
| Start Date | 2019-05-29 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06096688
The ClinicalTrials.gov registry entry for NCT06096688 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,508-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (26% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06096688 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06096688 about?
NCT06096688 is a clinical study titled "Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction". The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studie...
What is the current status of trial NCT06096688?
This trial is currently recruiting. The enrollment target is 1,120 participants. The study started on 2019-05-29. Estimated completion is 2026-12-31.
What conditions does trial NCT06096688 study?
This clinical trial studies the following conditions: Colorectal Cancer, Endometrial Cancer, Hereditary Cancer Syndromes.
Who is sponsoring clinical trial NCT06096688?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06096688 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.